Electromed, Inc. 10-Q

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. On September 9, 2025, we announced the approval of a stock repurchase authorization. Under this authorization, the Company may repurchase up to $10.0 million of outstanding shares of our common stock. The shares of our common stock may be repurchased under authorization on the open market or in privately negotiated transactions subject to applicable securities laws and regulations. The current repurchase authorization does not expire and as of March 31, 2026, a total of 151,911 shares have been repurchased under the authorization with an average cost of $25.79 per share. The approximate dollar value of shares that may yet be purchased under the plan as of March 31, 2026, was approximately $6,082,000. The following table sets forth information concerning all repurchases of shares of our common stock, including shares reacquired to satisfy tax withholding obligations upon vesting of restricted stock awards, for the three months ended March 31, 2026: Total Number of Approximate Dollar Shares Purchased Value of Shares that as Part of Publicly May Yet be Purchased Total Number of Average Price Announced Plans Under the Plans Period Shares Purchased Paid per Share or Programs or Programs January 1 – January 31, 2026 5,470 $ 27.72 5,470 $ 6,082,000 February 1 – February 28, 2026 - $ - - $ 6,082,000 March 1 – March 31, 2026 - $ - - $ 6,082,000 Total 5,470 5,470 Item 3. Defaults Upon Senior Securities. None. Item 4. Mine Safety Disclosures. None.